Screener
Lexicon Pharmaceuticals LXRX Gross margin
Gross margin at other companies
Other financials
Where this comes from
Calculated from Lexicon Pharmaceuticals’s reported figures.
Based on trailing twelve months.
The source filing: Lexicon Pharmaceuticals’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:05 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001062822-26-000117
FAQ
- What is Lexicon Pharmaceuticals's gross margin?
- Lexicon Pharmaceuticals (LXRX) reported gross margin of 99.1% in Q2 2026.
- How has Lexicon Pharmaceuticals's gross margin changed year-over-year?
- Lexicon Pharmaceuticals's gross margin decreased by 0.0% year-over-year, from 99.2% to 99.1%.
- What is the long-term trend for Lexicon Pharmaceuticals's gross margin?
- Over 5 years (2020 to 2025), Lexicon Pharmaceuticals's gross margin has grown at a 1.6% compound annual growth rate (CAGR), from 92% to 99.4%.
- What does gross margin mean?
- Gross profit (revenue minus cost of revenue) as a percentage of revenue, on a trailing-twelve-month basis. Measures how much of each sales dollar survives the direct cost of producing the goods or services sold.
Ask your AI about Lexicon Pharmaceuticals's gross margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude